Based on our molecular mimicry hypothesis between ZIKV sequence IVNDT and human proteins Cav1.2 and HSP70 12A, it is presumed that ZIKALIVax cannot trigger GBS upon vaccination, reinforcing the attractivity of a such chimeric viral clone as a vaccine candidate against Zika. Here, CACNA1C is linked to Guillain-Barre syndrome.